×ðÁú¿­Ê±

EN
EN
  • ÓªÒµ×Éѯ

    Öйú£º

    Email: marketing@medicilon.com.cn

    ÓªÒµ×ÉѯרÏߣº400-780-8018

    £¨½öÏÞ·þÎñ×Éѯ£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©

    ´¨É³×ܲ¿µç»°: +86 (21) 5859-1500

    ÍâÑó£º

    +1(781)535-1428(U.S.)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

ÔÚÏßÁôÑÔ¡Á
µã»÷Çл»
News information
ÐÂÎÅ×ÊѶ

GLP-1s µÄÐÄÀí×÷ÓÃ

2023-09-12
|
»á¼ûÁ¿£º

GLP-1ÔÚ²î±ð×éÖ¯ÖоßÓжàÖÖ×÷ÓúÍÆÕ±éµÄÖÎÁÆDZÁ¦ ¡£

GLP-1 shows numerous actions in different tissues, and a broad therapeutic potential.

GLP-1µÄÖ÷Òª×÷ÓÃÊǴ̼¤ÒȵºËØÉø͸²¢ÒÖÖÆÒȸßѪÌÇËØÉø͸£¬´Ó¶øÓÐÖúÓÚ¿ØÖƲͺóѪÌDz¨¶¯ ¡£

The main actions of GLP-1 are to stimulate insulin secretion and to inhibit glucagon secretion,thereby contributing to limit postprandial glucose excursions.

GLP-1 ¿ÉÒÔÔöÇ¿±¥¸¹¸Ð¶øµ¼ÖÂÌåÖؼõÇᣬ±ðµÄ£¬GLP-1»¹ÒÖÖÆ賦µÀÔ˶¯ºÍÉø͸£¬¿ÉÒԳ䵱³¦Î¸Ëغ͡°»Ø³¦Öƶ¯¡±»úÖƵÄÒ»²¿·Ö ¡£

GLP-1 also causes weight loss by increasing satiety. In addition, GLP-1 also inhibits gastrointestinal motility and secretion,and thus acts as an enterogastrone and part of the "ileal brake" mechanism.

¸ü¶à¡°GLP-1¡±×ÊѶ

¡°GLP-1¡±ÐÂÒ©Ñз¢·þÎñƽ̨

ÒȸßѪÌÇËØÑùëÄ-1(GLP-1s) ÏÈÈÝ

GLP-1ÈÃ×¢Éä³ÔÒ©Ò²Äܼõ·Ê³ÉΪÏÖʵ

Õë¶ÔNASH·Ç¾Æ¾«ÐÔÖ¬·¾¸ÎÓÐÄÄЩ²î±ðµÄÐÂÒ©ÀàÐÍ

Ïà¹ØÐÂÎÅ
¡Á
ËÑË÷ÑéÖ¤
µã»÷Çл»
ÍøÕ¾µØͼ
ÓÑÇéÁ´½Ó£º×ðÁú¿­Ê±  orangeƽ̨  ãåÃù2  ±´Ë¹ÌØÈ«Çò×îÉÝ»ª  ×¯ÏкÍÍøÖ·  yd2333Ôƶ¥µç×ÓÓÎÏ·  jdbµç×ÓÓÎϷƽ̨  ½ðʨ¹ó±ö»á3420055  pgµç×Ó  cq9µç×Ó  ±Ø·¢7790  ×ðÁú¿­Ê±  williamÍþÁ®ÑÇÖÞ¹Ù·½  918²©ÌìÓéÀÖ¹ÙÍøÊ×Ò³  pgµç×Ó